Linezolid- and vancomycin-resistant enterococcus faecium endocarditis: Successful treatment with tigecycline and daptomycin

Journal of Hospital Medicine

Volumn 2, Issue 5, 2007, Pages 343-344

  Jenkins, Ian ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CHLORAMPHENICOL; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; DOXYCYCLINE; FLUCONAZOLE; GENTAMICIN; GLUCOSE; INSULIN; LINEZOLID; MEROPENEM; STREPTOMYCIN; TIGECYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTERIOVENOUS FISTULA; ARTICLE; BACTERIAL ENDOCARDITIS; BACTERIAL GROWTH; BLOOD CULTURE; CANDIDA PARAPSILOSIS; CANDIDIASIS; CASE REPORT; CORONARY ARTERY DISEASE; DELIRIUM; DIABETES MELLITUS; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENDOCARDITIS; ENTEROBACTER CLOACAE; ENTEROBACTER INFECTION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; HEART MURMUR; HUMAN; HYPOGLYCEMIA; KIDNEY FAILURE; MALE; MITRAL VALVE REGURGITATION; NAUSEA; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERIPHERALLY INSERTED CENTRAL VENOUS CATHETER; PRIORITY JOURNAL; SEPTIC SHOCK; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

ACETAMIDES; ANTI-BACTERIAL AGENTS; DAPTOMYCIN; DRUG RESISTANCE, BACTERIAL; DRUG THERAPY, COMBINATION; ENDOCARDITIS, BACTERIAL; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MALE; MIDDLE AGED; MINOCYCLINE; OXAZOLIDINONES; TREATMENT OUTCOME; VANCOMYCIN;

EID: 35648930999     PISSN: 15535592     EISSN: 15535606     Source Type: Journal    
DOI: 10.1002/jhm.236     Document Type: Article

References (8)

1. Stevens MP, Edmond MB. Endocarditis due to vancomycin-resistant enterococci: case report and review of the literature. Clin Infect Dis. 2005;41:1134-1142.
2. Torres-Viera C, Dembry LM. Approaches to vancomycin resistant enterococci. Curr Opin Infect Dis. 2004;17:541-547.
3. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;4:633-638.
4. Lefort A, Lafaurie M, Massias L, et al. Activity and diffusion of tigecycline (GAR-936) in experimental enterococcal endocarditis. Antimicrob Agents Chemother. 2003;47:216-222.
5. Fowler VG, Boucher HW, Corey GR, et al. Daptomycin versus standard therapy for bacteremia and endocarditis caused by staphylococcus amens. New Engl J Med. 2006;355: 653-665.
6. Segreti JA, Crank CW, Finney MS. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients. Pharmacotherapy. 2006;26:347-352.
7. Poutsiaka DD, Skiffington S, Miller KB, Hadley S, Snydman DR. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J Infect. 2007;54:567-571.
8. Kvirikadze N, Suseno M, Vescio T, Kaminer L, Singh K. Daptomycin for the treatment of vancomycin resistant Enterococcus faecium bacteremia. Scand J Infect Dis. 2006;38: 290-292.